Asthma therapeutics market seen reaching $47.87 billion by 2030

By AI, Created 11:09 AM UTC, May 20, 2026, /AGP/ – The Business Research Company says the asthma therapeutics market rose to $35.73 billion in 2026 and is projected to hit $47.87 billion by 2030, driven by rising asthma prevalence, biologics and digital care tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - The asthma therapeutics market is expanding as more patients need treatments that can control inflammation, reduce attacks and support long-term disease management. - Rising asthma prevalence and wider access to newer therapies are increasing demand for both rescue medications and maintenance treatments. - The market outlook points to continued investment in biologics, combination inhalers and digital monitoring tools that could reshape asthma care.

What happened: - The Business Research Company said the global asthma therapeutics market grew from $33.11 billion in 2025 to $35.73 billion in 2026. - The company projected the market will reach $47.87 billion by 2030. - The forecast implies a 7.6% compound annual growth rate from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Asthma therapeutics include fast-acting relief medicines and longer-term treatments designed to reduce airway inflammation and prevent future episodes. - The market’s recent growth has been supported by limited availability of biologic treatments, heavy use of short-acting beta agonists and more frequent hospital and specialty clinic visits. - Broader adoption of oral and inhaled medicines also supported expansion. - The report cites emerging biologics and combination therapies as key drivers of future growth. - Telemedicine and digital health monitoring platforms are expected to add momentum. - Improved healthcare access in developing regions is another growth factor. - Research and drug-development spending is contributing to the forecast. - The report highlights growing use of personalized asthma treatments, inhalers, biologics, home-based care and remote monitoring. - The market is also seeing more attention on pediatric and elderly asthma management. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market story is shifting from broad symptom relief to more targeted and technology-enabled care. - Faster growth in Asia-Pacific suggests the biggest upside may come from expanding diagnosis rates, care access and treatment adoption in developing health systems. - The emphasis on remote monitoring and home-based care points to a longer-term move away from clinic-only asthma management.

What’s next: - The market is expected to keep growing through 2030 as preventive care, biologics and digital tools gain broader use. - More investment in drug development could widen treatment choices and support personalized care. - Download a free sample of the asthma therapeutics market report. - View the full asthma therapeutics market report.

The bottom line: - Asthma therapeutics is a growing global market, and the next phase of expansion is likely to be driven by better-targeted medicines, digital care and rising demand in faster-growing regions.